SYNGAP1, synaptic Ras GTPase activating protein 1, 8831
N. diseases: 145; N. variants: 80
Source: ALL
Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 6 | 33427422 | intron variant | G/A;T | snv |
|
Mental Disorders | 0.700 | 1.000 | 3 | 2015 | 2019 | ||||||||
|
1.000 | 0.120 | 6 | 33421604 | intron variant | G/T | snv | 0.41 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.120 | 6 | 33453800 | intron variant | T/C | snv | 0.42 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
1.000 | 0.040 | 6 | 33427422 | intron variant | G/A;T | snv |
|
Mental Disorders | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
1.000 | 0.160 | 6 | 33446566 | intron variant | G/A | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms | 0.700 | 0 | |||||||||||
|
0.925 | 0.160 | 6 | 33432700 | stop gained | C/T | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 1.000 | 18 | 2004 | 2017 | ||||||||
|
0.925 | 0.160 | 6 | 33432700 | stop gained | C/T | snv |
|
0.700 | 1.000 | 18 | 2004 | 2017 | |||||||||
|
1.000 | 6 | 33440943 | stop gained | C/T | snv |
|
0.700 | 1.000 | 18 | 2004 | 2017 | ||||||||||
|
1.000 | 0.160 | 6 | 33432724 | stop gained | C/T | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms | 0.700 | 1.000 | 2 | 2013 | 2016 | ||||||||
|
1.000 | 0.160 | 6 | 33446710 | stop gained | C/T | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms | 0.700 | 1.000 | 2 | 2015 | 2016 | ||||||||
|
1.000 | 0.160 | 6 | 33432787 | stop gained | C/T | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms | 0.700 | 0 | |||||||||||
|
0.882 | 0.200 | 6 | 33441318 | stop gained | C/T | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases | 0.700 | 0 | |||||||||||
|
0.882 | 0.200 | 6 | 33441318 | stop gained | C/T | snv |
|
0.700 | 0 | ||||||||||||
|
0.882 | 0.200 | 6 | 33441318 | stop gained | C/T | snv |
|
Behavior and Behavior Mechanisms | 0.700 | 0 | |||||||||||
|
0.882 | 0.200 | 6 | 33441318 | stop gained | C/T | snv |
|
0.700 | 0 | ||||||||||||
|
0.882 | 0.200 | 6 | 33441318 | stop gained | C/T | snv |
|
0.700 | 0 | ||||||||||||
|
0.882 | 0.200 | 6 | 33441318 | stop gained | C/T | snv |
|
Eye Diseases | 0.700 | 0 | |||||||||||
|
0.882 | 0.200 | 6 | 33441318 | stop gained | C/T | snv |
|
0.700 | 0 | ||||||||||||
|
0.882 | 0.200 | 6 | 33441318 | stop gained | C/T | snv |
|
0.700 | 0 | ||||||||||||
|
0.882 | 0.200 | 6 | 33441318 | stop gained | C/T | snv |
|
Mental Disorders | 0.700 | 0 | |||||||||||
|
0.882 | 0.200 | 6 | 33441318 | stop gained | C/T | snv |
|
Behavior and Behavior Mechanisms | 0.700 | 0 | |||||||||||
|
0.882 | 0.200 | 6 | 33441318 | stop gained | C/T | snv |
|
Behavior and Behavior Mechanisms | 0.700 | 0 | |||||||||||
|
0.882 | 0.200 | 6 | 33441318 | stop gained | C/T | snv |
|
0.700 | 0 | ||||||||||||
|
0.882 | 0.200 | 6 | 33441318 | stop gained | C/T | snv |
|
0.700 | 0 | ||||||||||||
|
0.882 | 0.200 | 6 | 33441318 | stop gained | C/T | snv |
|
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms | 0.700 | 0 |